Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Testing a decision-support tool for patients with head and neck cancer

Official title: Feasibility Testing a Decision-support Intervention for Clinical Trials

Run by University of Aarhus · NCT06291610 · Data updated 2026-11-12

This study is testing a new support tool to help patients with head and neck cancer make better choices about joining clinical trials.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Aarhus
Academic / other
Locations1 site (Aarhus)
StatusRecruiting
StartedFebruary 19, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedMarch 4, 2024
Trial IDNCT06291610 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who have been diagnosed with cancer of the pharynx or larynx and can communicate in Danish.

Probably not a fit

Patients with dyslexia may not benefit from this study due to potential challenges in understanding the decision aid materials.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study develops and tests a decision-support intervention aimed at helping patients with laryngeal and pharyngeal cancer make informed choices about participating in clinical trials. The intervention includes a tailored patient decision aid, decision coaching consultations with trained healthcare professionals, and a training program for these coaches. The feasibility of this intervention will be assessed by comparing responses from 60 patients before and after engaging with the decision support tools. The primary focus is on enhancing patient involvement in clinical trial decision-making.

Why it matters

Potential benefit: If successful, this intervention could empower patients to make more informed decisions regarding their participation in clinical trials.

How similar studies have gone: While decision-support interventions are emerging, this specific approach tailored for clinical trial participation is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with cancer of the pharynx or larynx
* Received verbal information regarding DAHANCA 35
* Read the patient information folder from DAHANCA 35
* Above 18 years
* Danish speaking

Exclusion Criteria:

* Dyslexia

Where it's running

  • Aarhus University Hospital
    Aarhus, Denmark
    Recruiting

Study contacts

  • Principal investigator: Jeppe Friborg, MD, PhD — Copenhagen University Hospital, Rigshospitalet
  • Study coordinator: Anne Kristensen, MSc
  • Email: annkrs@rm.dk
  • Phone: +4530315605

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.